Galectin 3 (LGALS3) (N-Term) Peptid
LGALS3
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5512360
Kurzübersicht für Galectin 3 (LGALS3) (N-Term) Peptid (ABIN5512360)
Target
Galectin 3 (LGALS3)
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- FSLHDALSGS GNPNPQGWPG AWGNQPAGAG GYPGASYPGA YPGQAPPGAY
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LGALS3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Galectin 3 (LGALS3)
-
Substanzklasse
- Chemical
-
Hintergrund
-
This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. Alternate splicing results in multiple transcript variants.
Alias Symbols: LGALS3, MAC2,
Protein Size: 250 -
Gen-ID
- 3958
-
NCBI Accession
- NP_002297
-
UniProt
- P17931
Target
-
Sie sind hier:
